Tufia C. Haddad

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0001-8226-3581

发表论文 280 篇 · 总被引 5995 次 · h-index 37

代表论文

• Cancer CARE (Connected Access and Remote Expertise) Beyond Walls — Safety, Feasibility, and Patient Experience of Home-Based Chemotherapy (2026 · NEJM Catalyst · 被引 1)
• Abstract P3-12-20: NRG-BR009: A phase III trial evaluating addition of adjuvant chemotherapy to Ovarian Function Suppression + Endocrine Therapy in premenopausal women with pN0-1, HR+/HER2- breast cancer (BC) and Oncotype Recurrence Score (RS) ≤25 (OFSET) (2025 · Clinical Cancer Research · 被引 1)
• ETHIC-COM AI: A Conceptual Framework for Inclusive AI Risk Communication (Preprint) (2026)
• A Multiregional Decentralized Clinical Trial Program to Improve Access (2026 · JAMA Network Open)
• WeCare intervention to improve breast cancer screening and research preparedness in rural and low-socioeconomic women: study protocol for a community-engaged feasibility trial (2026 · BMJ Open)
• A phase III trial evaluating addition of adjuvant chemotherapy to ovarian function suppression + endocrine therapy in premenopausal women with pN0-1, HR+/HER2– breast cancer and Oncotype recurrence score ≤ 25 (OFSET): NRG-BR009. (2026 · Journal of Clinical Oncology)